Literature DB >> 19031475

Gastrointestinal stem cells in development and cancer.

S Brabletz1, O Schmalhofer, T Brabletz.   

Abstract

An enormous body of knowledge about the biology of stem cells and their role in development, tissue homeostasis and cancer formation has been gained in the last 20 years. This review gives a comprehensive overview on knowledge about localization and regulation of normal gastrointestinal stem cells and links it to our understanding of gastrointestinal tumourigenesis and malignant progression in the light of the cancer stem cell concept. The focus is on intestinal stem cells and newly identified stem cell factors, such as the beta-catenin target gene Lgr5. The basis of intestinal stem cell regulation is a permanent crosstalk between epithelial and underlying mesenchymal cells in the intestinal stem cell niche. This crosstalk is mediated by crucial pathways, including the Wnt, Hedgehog (HH), Notch, PI3K and BMP pathways. Disturbances in this fine-regulated interaction can both initiate intestinal tumours and, in association with additional genetic alterations or environmental activation of embryonic processes such as epithelial-mesenchymal transition (EMT), lead to tumour invasion and metastasis.

Entities:  

Mesh:

Year:  2009        PMID: 19031475     DOI: 10.1002/path.2475

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  70 in total

1.  Controversies in cancer stem cells: targeting embryonic signaling pathways.

Authors:  Naoko Takebe; S Percy Ivy
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

Review 2.  High-throughput screening strategies for targeted identification of therapeutic compounds in colorectal cancer.

Authors:  Agnieszka B Bialkowska; Vincent W Yang
Journal:  Future Oncol       Date:  2012-03       Impact factor: 3.404

Review 3.  Cancer stem cells: a novel paradigm for cancer prevention and treatment.

Authors:  Dharmalingam Subramaniam; Satish Ramalingam; Courtney W Houchen; Shrikant Anant
Journal:  Mini Rev Med Chem       Date:  2010-05       Impact factor: 3.862

4.  The zebrafish flotte lotte mutant reveals that the local retinal environment promotes the differentiation of proliferating precursors emerging from their stem cell niche.

Authors:  Kara L Cerveny; Florencia Cavodeassi; Katherine J Turner; Tanya A de Jong-Curtain; Joan K Heath; Stephen W Wilson
Journal:  Development       Date:  2010-05-26       Impact factor: 6.868

5.  Overexpression of nuclear β-catenin at invasive front in rectal carcinoma is associated with lymph node metastasis and poor prognosis.

Authors:  L Wang; X Zhang; Z Li; J Chai; G Zhang; Z Yu; Y Cheng; S Hu
Journal:  Clin Transl Oncol       Date:  2013-09-17       Impact factor: 3.405

Review 6.  [Prognostic biomarkers for metastatic colorectal cancer].

Authors:  J H L Neumann
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

Review 7.  Intestinal stem cells and celiac disease.

Authors:  Anna Chiara Piscaglia
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

8.  Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

9.  Notch1 Autoactivation via Transcriptional Regulation of Furin, Which Sustains Notch1 Signaling by Processing Notch1-Activating Proteases ADAM10 and Membrane Type 1 Matrix Metalloproteinase.

Authors:  Hong Qiu; Xiaoying Tang; Jun Ma; Khvaramze Shaverdashvili; Keman Zhang; Barbara Bedogni
Journal:  Mol Cell Biol       Date:  2015-08-17       Impact factor: 4.272

10.  Expression of survivin detected by immunohistochemistry in the cytoplasm and in the nucleus is associated with prognosis of leiomyosarcoma and synovial sarcoma patients.

Authors:  Helge Taubert; Chris Heidenreich; Hans-Jürgen Holzhausen; Antje Schulz; Matthias Bache; Matthias Kappler; Alexander W Eckert; Peter Würl; Ingo Melcher; Kathrin Hauptmann; Steffen Hauptmann; Klaus-Dieter Schaser
Journal:  BMC Cancer       Date:  2010-02-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.